ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • Subscription
  • Newsletter
  • Advertise
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

APPOINTMENTS

scott-schulz.jpg

Go West

British research service provider Envigo has appointed Scott Schulz to the post of Director, North American Operations. Schulz joins Envigo from Taconic Biosciences, where he was VP of Operations. more ➔

Bildbeschreibung

Founder on board

Frode Marc Bohan has been reelected as Chairman of the Board of Directors for Norwegian Vitamin K2 expert NattoPharma ASA. He will continue to chair the board for the next two years. more ➔

ADVERTISEMENT

jozsef-balla.jpg

Scientific insight

Swedish preeclampsia drug developer A1M Pharma has named Hungarian kidney specialist József Balla as the newest member of its scientific advisory board. more ➔

doude-van-troostwijk.jpg

Marketing man

Hansa Medical, a Swedish biopharmaceutical company focusing on novel immunomodulatory enzymes, has appointed Henk Doude van Troostwijk as Vice President, Commercial Operations. more ➔

Bildbeschreibung

The doctor is in

Belgian CRO and service provider Genea has appointed a new Chief Medical Officer. Jörn Balzer will be responsible for the clinical, safety and risk management in Genae’s research services. more ➔

ADVERTISEMENT

ulf-hannelius.jpg

Building a diabetes major

Diabetes vaccine developer Diamyd Medical has a new CEO. From now on, Ulf Hannelius will lead the Stockholm-based company. more ➔

Page 45 of 45«‹434445

LATEST NEWS

Photo of Roche Tower by Basil Minhaj via Unsplash+

Roche bets up to $813M on Zymeworks lung cancer can...

The Leadership Edit Thumbnail European Biotechnology

Sensorion names CMO; Orano Med adds CSO; CRISPR The...

scrap paper

Roche scraps off-the-shelf CAR-T from Poseida deal...

ADVERTISEMENT

MAGAZINE

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

SPONSORED PUBLICATION

1 / 3
Team Invitris
artificial intelligence

Closing AI medicine’s manufacturing gap

At the IZB in Martinsried, Invitris is developing a cell-free platform to turn ­digital sequences into proteins, antibodies and phages within hours. CEO Patrick Grossmann explains why AI is shifting … more ➔

2 / 3
IDT Biologika
CRO & CDMO

From development to commercial reality

Helping biopharmaceutical innovators build scalable, manufacturable, and commercially viable processes from the start. more ➔

3 / 3
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top